Home » Topics » Regulatory

Regulatory
RSS

ACE inhibitor introduced in U.S. for reducing cardiovascular events in patients at risk

Jan. 29, 2001

AstraZeneca discontinues development of Zendra

Jan. 26, 2001

Results with extended-release ciprofloxacin product promising, reports DepoMed

Jan. 25, 2001

NDA filed in U.S. for once-daily Xatral

Jan. 25, 2001

Recombinant hGH approved in E.U. for Turner's syndrome

Jan. 24, 2001

Cangene's chickenpox vaccine approved in Canada

Jan. 23, 2001

Oral formulation of Fludara now available in U.K.

Jan. 23, 2001

Schering-Plough submits two new applications for desloratadine in the E.U.

Jan. 22, 2001

Use of rhIL-11 for the treatment of hemorrhagic shock described by Genetics Institute

Jan. 19, 2001

Novel combination therapies useful for weight gain associated with antipsychotic drugs

Jan. 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...